Please login to the form below
9
Revenue 2017Gilead Sciences
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.
Gilead signs $300m deal with Dragonfly to advance immunotherapies
Gilead will make an upfront payment of $300m to Dragonfly, with an option for further royalties of up to 20% on global net sales. ... Gilead will gain an exclusive, global licence for DF7001, part of a 5T4-targeting investigational immunotherapy programme
FDA approves COVID-19 treatment for those under the age of 12
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application for Veklury. ... With the recent opening of our Gilead Pediatric Center of Excellence in Dublin, which is responsible for
Gilead’s Veklury significant decreases risk of hospitalisation for COVID-19 patients
New analysis from a phase 3 double-blind, placebo-controlled trial has shown that a three-day course of Gilead’s Veklury significantly decreases the risk of hospitalisation among COVID-19 ... patients. The studies, conducted by Gilead Sciences,
Kite’s new CAR T-cell therapy manufacturing facility given the go-ahead by the FDA
Kite, a Gilead Company, has announced that the US Food and Drug Administration (FDA) has approved the launch of commercial production at its new CAR T-cell therapy manufacturing facility.
BMS Foundation announces Robert A Winn Diversity in Clinical Trials Award Program
As a new supporter of the programme, Gilead Sciences will donate $14m over the next four years. ... BMSF has committed to support 250 Winn Career Development Awards and 250 Winn Pipeline Awards, alongside further backing from Gilead Sciences, pledging
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- Recognising HIV Vaccine Awareness Day
- NICE recommends AstraZeneca’s Imfinzi for adults with non-small cell lung cancer
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- J&J appoints Thibaut Mongon as CEO designate of New Consumer Health Company
- Live Webinar: The Future of MedTech: Streamlined Clinical Data Collection & Management
- Medscape: Connect to the conversation
- A Medscape 4-part video interview series
- Why big pharma needs to be braver
- MadMicrobe Studios Inc Announces New European Venture
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
PMHub
Genetic Digital
Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...
Latest intelligence
- Why big pharma needs to be braver
- The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
